Delgocitinib Cream/Ointment
Topical pan-JAK inhibitor for eczema and chronic hand eczema
About This Treatment
Delgocitinib is a topical pan-JAK inhibitor used in Japan for atopic dermatitis and recently studied/approved in some regions for chronic hand eczema. It is useful when topical steroids are inadequate or inappropriate.
Hand eczema management still requires irritant/allergen control and barrier protection.
Mechanism of Action
Topical pan-JAK inhibition reduces local cytokine signaling and itch/inflammation pathways in skin.
Indications
Expected Results
DELTA 1/2 showed improved IGA-CHE treatment success and patient-reported itch/pain in moderate-to-severe chronic hand eczema.
Clinical Evidence
Risks & Side Effects
Application irritation, folliculitis, acneiform eruption and infection worsening may occur. Broad/long-term use requires medical supervision.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition